Name: Dementia Care 2019
Start: 2019-07-24
End: 2019-07-26
Location: Italy

Conference Information

About Conference

On behalf of Pulsus Group, we are honoured to invite you to join the 10^thInternational Conference on Dementia and Dementia Care which will be held from July 24-25, 2019 at Rome, Italy.

The conference will be organized around the theme “Enlightening the Advancements in Dementia Research and Care”.

Dementia Care 2019 has been planned and implemented in accordance with the accreditation requirements and policies of the Committee.We will likely convey an extraordinary program which covers the whole range of research in Dementia and Dementia care and share the multifaceted encounters of different treatment methodology and Care Practices.

Dementia Care 2019 is an annual gabfest which glazes the entire range of research in Dementia and Dementia care and shares the various encounters of different treatment methodology and Care Practices. It is the platform for all the innovators, researchers, organizations, scholars, caretakers to discuss and exhibit the recent advancements in the treatment, care and management of Dementia and it also brings together the researchers to dissertate novel drug discovery, technical development in care methods, on-going clinical trials, end of life issues and organizational development.

Dementia remains as one of the challenges in health care Internationally. It is reported that, across the globe about 35.6 million are living with Dementia and it is expected to double by 2030 and triple by 2050.

This conference will provide scope for all the proficient people in the field of Neuroscience and Psychiatry to accomplish their research relationships with each other and to discover global associates for future collaboration.

Who should attend?

Physicians
Geriatricians
Students
Clinical Neurologist
Speech Therapists
Research Faculty
Scientists and professors
Physical Therapists
Nurses
Health Organizations
Social Workers
Persons living with Dementia
Dementia Advocates
Neurologists
Health Care Analysts
Researchers in field of Neurology
Health care organizations
Geriatric Psychiatrists
All those providing care and treatment to patients with Dementia.

Why to attend?

With members from around the world focused on learning about Dementia and its advances; this is your best opportunity to reach the largest assemblage of participants from the Dementia community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new discoveries in the Dementia treatment and diagnosis, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Dementia Care, treatment, diagnosis are hallmarks of this conference.

For Researchers and Faculty Members:

Speaker Presentations
Poster Display
Symposium hosting (4-5 member team)
Workshop organizing

For Universities, Associations & Societies:

Association Partnering
Collaboration proposals
Academic Partnering
Group Participation

For Students and Research Scholars:

Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
Student Attendee
Group registrations

For Business Delegates:

Speaker Presentations
Symposium hosting
Book Launch event
Networking opportunities
Audience participation

For Product Manufacturers:

Exhibitor and Vendor booths
Sponsorship opportunities
Product launch
Workshop organizing
Scientific Partnering
Marketing and Networking with clients

Scientific Sessions

Session 01: Dementia

Dementia is a chronic Neurodegenerative disorder in which the complete deterioration of the intellectual functioning and behaviour occurs. It results in progressive memory loss, thus affecting the lifestyle of the people. Dementia is not a single disease entity rather it is the group of symptoms. The common symptoms include personality changes, inability to recognize, emotional problems, a failing sense of direction.

It is stated by Alzheimer's society that around 50 million people are living with Dementia and it is also stated that for every three seconds, a person is developing Dementia. Dementia is prevailing as one of the priority conditions in the field of medicine. Dementia is main leading cause of death in England and Wales over heart diseases. Alzheimer’s disease is 6th leading cause of death in the USA and it kills more than breast and prostate cancer combined. To solve problems of globally various Dementia conferences are arranged to find cure for Dementia society universally.

Related Conference: International Conference on Neurodegenerative Disorders & Stroke , February 27-28, 2019, Paris, France | Global Summit on Neuroscience and Neuroimmunology, May 22-23, 2019, London, UK | Annual Meeting on Neurosurgery and Neurological Surgeons, May 22-23, 2019, London, UK | Annual Conference on Brain Disorders, Neurology and Therapeutics, June 10-11, 2019, Dublin, Ireland | International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, June 10-11, 2019, Dublin, Ireland | Global Experts Meeting on Psychiatry and Mental Health, June 17-18, 2019, Rome, Italy

Session 02: Clinical Stages in Dementia Progression

The Reisberg scale is used to indicate the disease progression. If the person has no memory loss and if he/she is mentally stable and healthy, i.e, a normal person, is said to be in no cognitive stage of the syndrome. The stage 2 or very mild cognitive decline has no evident symptoms, due to ageing the forgetfulness, which is the common symptom emerges during this stage. During the third stage i.e, mild cognitive decline stage people experience increased forgetfulness, and face difficulty in finding words. Stage 4 or moderate cognitive decline includes severe symptoms like decrease in concentration, and the person faces difficulty such that he /she could not travel alone. In stage 5 or moderately severe cognitive decline occurs such that people have difficulties in completing tasks and people start withdrawing from social activities. Next is the middle dementia where the people tend to forget the recent memory activities. The last stage is that they have no ability to talk or communicate. They completely require human help and care.

Related Conference: International Conference on Neurology and Health Care , June 24-25, 2019, Rome, Italy | World Congress on Advanced Nutraceuticals and Functional Foods, July 15-16, 2019, London, UK | World Congress on Advances in Addiction Science and Medicine, July 24-25, 2019, Rome, Italy | World Congress on Psychology and Behavioral Science July 31-August 1, 2019, Netherlands | International Conference on Healthcare and Hospital Management, August 7-8, 2019, Singapore | Global Experts Meeting on Healthcare and Nursing, October 9-10, 2019, Madrid, Spain

Session 03: Alzheimer’s Disease

Alzheimer’s disease is most common type of Dementia. Alzheimer’s is a chronic Neurodegenerative disorder. Patient of Alzheimer’s shows early symptoms of short-term memory and later progresses to problems in language, disorientation. Causes of Alzheimer’s are not clear yet, but 70% of risks are associated with genetics. There are no existing treatments to reverse or stop Alzheimer’s. Most of patients with alzheimer’s are above 65 years of age but 4-5% cases are of early onset Alzheimer’s. It’s still one of the costly diseases. Separate Alzheimer’s conferences have been arranged to make aware world for its consequences. In 2016, hundreds of conferences have main topic as Alzheimer’s disease as it contributes to 60-70% cases of Dementia. Several countries Governments are taking initiative in Alzheimer’s Congress such as UK, USA, Canada, France having high ratio of deaths due to Alzheimer’s patients and other Dementias.

Related Conference: World Congress on Global Healthcare, Oct 14-15, 2019, Rome, Italy | Global Summit on Healthcare and Nutrition, Nov 13-14, 2019, London, UK | World Congress on Mental Health, Nov 13-14, 2019, London, UK | International Conference on Neurology and Neuromuscular Diseases, Dec 4-5, 2019, Dubai, UAE | International Conference on Clinical and Experimental Neuropsychology, June 24-25, 2019, Rome, Italy

Session 04: Vascular Dementia

Vascular Dementia is second most common type of Dementia after Alzheimer’s. Brain has one of the richest networks, sudden changes in thinking causes problems in supply of oxygen and nutrients to brain, causes series of minor attacks. Vascular Dementia can’t be tracked until it has series of attacks. Death of brain cells causes problems in memory, thinking and reasoning. There are various types of Vascular Dementia such as Stroke-related Dementia, Post-stroke Dementia, Single-infarct and Multi-infarct Dementia, Sub cortical Dementia. High blood pressure, High blood cholesterol level, Diabetes are some risk factors which majorly contribute to the severity of Vascular Dementia. Vascular Dementia is common type of Dementia after Alzheimer’s disease contributing to nearly 20% cases making it significant in discussions of Dementia conferences.

Session 05: Dementia with Lewy Body

Alpha synuclein protein depositions in neurons cause Lewy body Dementia. Symptoms of Lewy body Dementia are hallucinations, rigidness in movement. In Lewy body Dementia, disruption among brain cells occur, after one year of observation and progression in symptoms with Parkinson’s disease the diagnosis of Lewy body Dementia is possible. If cognitive problems occur with a year of movement problems doctors declares it as Lewy body Dementia and if not then it is declared as Parkinson’s disease. It is normal kind of Dementia after Alzheimer's illness and having same cases as Vascular Dementia making it critical in interlocution of Dementia Conferences.

Related Conference: International Conference on Neurology and Health Care , June 24-25, 2019, Rome, Italy | World Congress on Advanced Nutraceuticals and Functional Foods, July 15-16, 2019, London, UK | World Congress on Advances in Addiction Science and Medicine, July 24-25, 2019, Rome, Italy | World Congress on Psychology and Behavioral Science, July 31-August 1, 2019, Netherlands | International Conference on Healthcare and Hospital Management, August 7-8, 2019, Singapore | Global Experts Meeting on Healthcare and Nursing, October 9-10, 2019, Madrid, Spain

Session 06: Frontotemporal Dementia

Frontotemporal Dementia also known as Pick’s disease is broad term for group of disorders caused by progressive nerve cell loss in the frontal and temporal lobes of brain. Spindle neurons have 70% loss in Frontotemporal Dementia patients while other neurons remain unchanged. Temporal lobes have specific function such as right temporal lobe involved in recognition of faces and known objects. Left temporal lobe involved in meaning of names and words of objects. Frontotemporal Dementia includes changes in behavior, personality and difficulty in speech. It is significant cause of in younger people. MRI scans may show the frontal and temporal lobe atrophy.

Session 07: Posterior Cortical Atrophy

Posterior Cortical Atrophy also called as Benson's syndrome is a abberant variant of Alzheimer's disease, where the symptom is identified at the different part of the brain. It is one of the common Neuro degenerative disorderswhere the degeneration occurs in the cortex region of the brain. It is also due to the accumulation of amyloid protein in that region. The PCA affected patients show amyloid plaques and tangles in the neurofibrils. The challenge is that this syndrome shows distinct Neuropsychological deficits still remaining as the complicated forms of Dementia. PCA has been recognized for more than two decades, and yet the condition is almost abandoned by researchers. Hence it is the most suitable topic for discussion in the Dementia conferences.

Session 08: Parkinson Disease Dementia

Parkinson's disease Dementia is a cognitive decline in thinking and reasoning that develops in the person diagnosed with Parkinson's disease at least a year earlier. Parkinson's Dementia are similar to those caused by other health issues. For example, mental health issues such as depression can mimic Dementia. The reason behind development of Dementia is not completely understood in Parkinsons disease patient. Hence this Dementia conference will provide a platform to discuss the problem.

Related Conference: International Conference on Neurology and Health Care , June 24-25, 2019, Rome, Italy | World Congress on Advanced Nutraceuticals and Functional Foods, July 15-16, 2019, London, UK | World Congress on Advances in Addiction Science and Medicine, July 24-25, 2019, Rome, Italy | World Congress on Psychology and Behavioral Science, July 31-August 1, 2019, Netherlands | International Conference on Healthcare and Hospital Management, August 7-8, 2019, Singapore | Global Experts Meeting on Healthcare and Nursing, October 9-10, 2019, Madrid, Spain

Session 09: Diseases associated with Dementia

The neurological conditions in which the Dementia occurs include some disorders like Parkinson's disease, Normal Pressure Hydrocephalus, Huntington's disease, and Creutzfeldt-Jakob disease (CJD). These diseases mimic Dementia or has Dementia as a major sign in the disease. The diseases associated with Dementia have the disease associates that include depression, brain tumors, nutritional deficiencies, head injuries, hydrocephalus, infections (AIDS, meningitis, syphilis), Drug reactions and Thyroid problems. The genetic factors are responsible for the establishment of disorders like Parkinsons disease, Down Syndrome, Creutzfeldt-Jakob disease, Normal Pressure Hydrocephalus, The other factors for Dementia includes physical factors like head injuries and Traumatic brain injuries.

Session 10: Neuroepigenetics in Dementia

Neuroepigenetics is the field in Neuro biology that replaces the conventional thoughts on heritable epigenetic mechanisms, which involves in histone and chromatin modification which results in the variable expression of genes in the CNS. The numerous neuroepigenetic mechanisms have been involved in several Neurological and Neurodegenerative diseases for the regulation of various epigenetic mechanisms. All the mechanisms in Epigenetics will have a biochemical characteristic such that it helps in regulation process. The basic principle of Neuroepigenetics is that once DNA methylation patterns are established upon the genome in terminally differentiated cells, those modifications are permanent and essentially immutable. Other epigenetic molecular mechanisms are also in play in neurons some are ATP-dependent chromatin remodeling, genomic imprinting, SNF2 chromatin remodeling.

Session 11: Causes and Risk Factors of Dementia

Causes of Dementia depend on areas of brain affected due to Dementia. Dementia is progressive in nature; Age is one of the most important risk factors of Dementia, 65years exceeding persons has more chances of having Dementia. Ageing and genetic inheritance from ancestors is beyond control but other risk factors such as Hypertension, Hyperlipidaemia, Hyperthoiroidism, Alcohol use in large amounts, smoking can be prevented or controlled. Head injury, Stroke or Brain tumor may cause Dementia. Few risk factors can be prevented with healthy lifestyle and proper diet. Causes and risk elements have contributed enormously in Dementia research and discovered new measures in Dementia conferences.

Related Conference: International Conference on Neurology and Health Care , June 24-25, 2019, Rome, Italy | World Congress on Advanced Nutraceuticals and Functional Foods, July 15-16, 2019, London, UK | World Congress on Advances in Addiction Science and Medicine, July 24-25, 2019, Rome, Italy | World Congress on Psychology and Behavioral Science, July 31-August 1, 2019, Netherlands | International Conference on Healthcare and Hospital Management, August 7-8, 2019, Singapore | Global Experts Meeting on Healthcare and Nursing, October 9-10, 2019, Madrid, Spain

Session 12: Bioinformatics Approach in Dementia Research

Bioinformatics advent can be used to regulate and evaluate data from the current high-throughput research technologies and render means for novel discoveries in the field of Neurodegenerative diseases. It is reported that there is a very little published data on Epigenomics. It is said that the data are obtained from high through put technologies in screening of human brain. These data intend the upcoming researchers to know and design their experiments. The Data Mining plays an important role in the prediction of the disorder, where the actual data is compared with the real data and the results are interpreted. The Transcriptomics and Proteomics studies has also been carried out providing necessary solutions for the problems.

Session 13: Recent Advances in Dementia Diagnosis

The assessment of Dementia in needed to rule out similar symptoms showing to such diseases such as depression, delirium which is curable. It is necessary to provide time to Dementia patients to plan future and make them literate about the possible effects in the future. There are various tests for diagnosing Dementia such as Mini Mental State Examination (MMSE), Mental Score Test, Trail Making Test. MMSE test include series of exercises in which various problems are checked with memory, speech, ability to respond. Blood test is also done to check levels of vitamin B12 and Thyroid hormones, which may be responsible. Brain scans such as MRI and CT scans used for checking brain tumor and Strokes in Vascular Dementia. Neurology gatherings talked rigorously on Dementia Diagnosis and it is always misleading to different conditions like Parkinson’s' disease. Hence discovery and establishment of new methodologies and techniques for analysis is in the urge for the Dementia society for dependable diagnosis methods.

Session 14: Treatment Modalities of Dementia

Treatment modality is a method that is followed to treat a patient suffering from a disease condition. The treatment modalities have three main approaches ,which include medical, psychological and sociocultural approaches. The most important consideration is that, in practice, no single treatment is considered sufficient for the treatment of Dementia. By now the combination therapy which involves the use of two or more drugs proves to be efficient. The other treatment methods which involve the stem cell therapy and gene therapy has now created the spotlight in the Dementia Treatment. Hence the advanced treatment methods can be discussed in the conference.

Related Conference: International Conference on Neurology and Health Care , June 24-25, 2019, Rome, Italy | World Congress on Advanced Nutraceuticals and Functional Foods, July 15-16, 2019, London, UK | World Congress on Advances in Addiction Science and Medicine, July 24-25, 2019, Rome, Italy | World Congress on Psychology and Behavioral Science, July 31-August 1, 2019, Netherlands | International Conference on Healthcare and Hospital Management, August 7-8, 2019, Singapore | Global Experts Meeting on Healthcare and Nursing, October 9-10, 2019, Madrid, Spain

Session 15: Therapeutic Targets in Dementia

Therapeutic targets are bio molecules maybe a nucleic acid or a protein whose biological activity can be modified by a drug candidate. In some cases of Dementia, it is reported that proteins are the cause for the disease. For example the accumulation of amyloid protein in the regions of Brain acts as a major factor for the disorder, hence it can be a therapeutic target . Therapeutic targets play an important role in identifying the potential drug candidates . Hence the conference provides the discussion sessions to reveal the targets for drug design process.

Session 16: Clinical Trials and Drug Development

Rigorous clinical trials on Dementia drugs are continuing in USA and UK under the guidance of Alzheimer's society and it is reported that there is very less participation of people . The most of drugs are in second and third phases. Most of clinical trials are done in specific areas are amyloid beta plaques, the immune system, tau tangles . New medications for Dementia being developed in 2014/2015, 31% were named symptoms modifying. There are many developments are going on in Drug discovery of Dementia as old treatments are unable to stop the progression of Dementia. Most associations share their exploration on new medications for Dementia in Dementia conferences to get higher esteem to their items. This gets to be distinctly gainful to different geriatric doctors to redesign themselves with such medications and progressing possibilities by going to Dementia conferences. Such Dementia meetings will help researchers to know target areas for Drug development in Dementia and work towards it and also Dementia conferences exhibit clinical trial medications and offers positivity to discover new approaches in curing Dementia

Session 17: Dementia Awareness

Dementia is predominant disorder that affects a greater number of people around the world. Diagnosis of the patient with Dementia frightens the person affected by the syndrome, their family members and caretakers. Better understanding about public awareness of Dementia aids more effective health and social policies. Dementia Awareness in families affected by dementia and the public is important to get a better grasp on how dementia is perceived If it is not understood in detail about the level and depth of public awareness of dementia, then the communication is ineffective with people to help or educate and address misconceptions The Dementia conference discusses the Awareness to achieve higher rate of early diagnosis and the management of the disorder.

Related Conference: International Conference on Neurology and Health Care , June 24-25, 2019, Rome, Italy | World Congress on Advanced Nutraceuticals and Functional Foods, July 15-16, 2019, London, UK | World Congress on Advances in Addiction Science and Medicine, July 24-25, 2019, Rome, Italy | World Congress on Psychology and Behavioral Science, July 31-August 1, 2019, Netherlands | International Conference on Healthcare and Hospital Management, August 7-8, 2019, Singapore | Global Experts Meeting on Healthcare and Nursing, October 9-10, 2019, Madrid, Spain

Session 18: Care Practices in Dementia

Dementia patients need assistance and full-time care as much as drugs. Some common care practices in Dementia are assistance in food and fluid consumption, pain management, social engagement ensuring safety and security of Dementia patients. Main aim of care practices is to ensure cut in hospitalization and psychotropic drugs. Understanding patient’s mood changes, behaviour, speech problems and help in rectifying them. Dementia patients need end of life care so qualified nursing staff is needed. Few care practices which are used are indoor and outdoor activities, visual and audio stimulation, Art therapy. Care practices in Dementia have been critical to engage in international Dementia meetings. In need to evolve in Dementia care world gathering and genuine talks on Dementia care is required. The Dementia conference discusses the care practices to decrease the distress among the patient, family and caregivers.

Session 19: Rehabilitation and Dementia

Rehabilitation gives both an arrangement of controlling standards to shape a model of administration arrangement and a framework for supporting individuals with dementia and their families. There is a need to create rehabilitation benefit frameworks with a reasonable spotlight on enhancing working and supporting connections, personality, and commitment and a need to prepare Dementia Care staff to actualize rehabilitative mediation. It is basic to completely include individuals with dementia and carers to guarantee an intensive comprehension of their points of view. Acknowledging the right to rehabilitation offers a tremendous opportunity to create a focused and coherent approach to positive support for people with dementia, of any age, subtype, or severity, and their families.

Related Conference: International Conference on Neurodegenerative Disorders & Stroke , February 27-28, 2019, Paris, France | Global Summit on Neuroscience and Neuroimmunology, May 22-23, 2019, London, UK | Annual Meeting on Neurosurgery and Neurological Surgeons, May 22-23, 2019, London, UK | Annual Conference on Brain Disorders, Neurology and Therapeutics, June 10-11, 2019, Dublin, Ireland | International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases, June 10-11, 2019, Dublin, Ireland | Global Experts Meeting on Psychiatry and Mental Health, June 17-18, 2019, Rome, Italy

Session 20: Technology and Dementia

There are a wide range of advances can be adjusted to the necessities of somebody with dementia. A few bits of Assistive Technology have been composed particularly for individuals living with the condition yet a ton of possibly accommodating innovation has not developed. As of now many will be utilizing items or gadgets that could profit persons living with the condition. Technology’s causing treatment and Diagnosis paradigms are reconsidered now. The Digital Therapeutics and Digiceuticals enable more flexible treatment and monitoring alternatives for Treatment, diagnosis and Management of the condition.

Related Conference: International Conference on Neurology and Health Care , June 24-25, 2019, Rome, Italy | World Congress on Advanced Nutraceuticals and Functional Foods, July 15-16, 2019, London, UK | World Congress on Advances in Addiction Science and Medicine, July 24-25, 2019, Rome, Italy | World Congress on Psychology and Behavioral Science, July 31-August 1, 2019, Netherlands | International Conference on Healthcare and Hospital Management, August 7-8, 2019, Singapore | Global Experts Meeting on Healthcare and Nursing, October 9-10, 2019, Madrid, Spain

Session 21: Dementia Care Dos & Donts

Mid-to-late stage Dementia and Alzheimer's patients regularly present challenging behaviour issues for their family and their guardians. The anger, sadness, paranoia, confusion and fear they're encountering can result in oppositional, forceful and in some cases rough discourse or activities. Comprehension and realizing about Dos and Do not about Dementia procedures are best to know when working with dementia affected people and the conduct is vital to encourage the persons living with Dementia and keep up their prosperity. Thus, promoting a positive atmosphere for the persons living with Dementia becomes possible.

Session 22: Case reports

Case reports in Dementia supports the comprehensive report of causes, symptoms, treatment and possible outcome. Each case report distinguishes in conditions such as age, family background, treatment given and effects of it. This all helps to design, categorize the future aspects of disease. Case report will be highly helpful for the researchers to develop new methods for physicians to develop quick diagnosis methods in Dementia patients. Case reports in Dementia gives some thought regarding diagnosis, treatment and level of cure perhaps conceivable prevention to be taken moreover. Be that as it may, most recognized case reports is to be talked in the Dementia conference which would be extremely useful to researchers to carry on with their work.

Related Conference: World Congress on Global Healthcare, Oct 14-15, 2019, Rome, Italy | Global Summit on Healthcare and Nutrition, Nov 13-14, 2019, London, UK | World Congress on Mental Health, Nov 13-14, 2019, London, UK | International Conference on Neurology and Neuromuscular Diseases, Dec 4-5, 2019, Dubai, UAE | International Conference on Clinical and Experimental Neuropsychology, June 24-25, 2019, Rome, Italy

Market Analysis

Summary: Dementia Care 2019 welcomes attendees, presenters, and exhibitors from all over the world to Rome, Italy. We are delighted to invite you all to attend and register for the “10^thInternational Conference on Dementia and Dementia Care”, which is going to be held during July 24-25, 2019 at Rome, Italy. The Scientific committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We are very glad to invite you to join us at Dementia Care 2019, where you will be sure to have a meaningful experience with scholars from around the world. We all look forward to meeting you at Rome, Italy

Scope and Importance:

The conference will be organized around the theme “Enlightening the Advancements in Dementia Research and Care to bring together the Scientists, Professors, Health Organizations, Social Workers, Persons living with Dementia, all those providing care and treatment to patients with Dementia. Conference theme focuses on discussing the leading advancements in the field of Dementia Research and in Dementia Care. Also, this conference will provide scope for all the proficient people in the field of Neuroscience and Psychiatry to accomplish their research relationships with each other and to discover global associates for future collaboration. Around the world, around 44 million individuals are living with dementia, making the condition a worldwide crisis that must be addressed to. In Italy, more than 1.4 million individuals are living with dementia, the number of people living with dementia is projected to increase to 2.3 million in 2040 if prevalence proportions per age group are maintained, growing at 2.1% per year, compared with a decrease of 0.1% per year for the general population

Why Rome?

Rome, Italy’s capital, is a city with unifying cultures with almost 3,000 long periods of comprehensively powerful workmanship, design and culture in plain view. Ancient ruins show the power of Former Roman Emperors. Rome serves as home to about 4.2 million people, where 2.6 million are inhabitants. Rome has protracted, developed and accessible modes of transportation, Extensive metropolitan (metros), high-speed rail network, Buses help in moving the people of the city. Italy experiences a Mediterranean climate with its hot, dry summers and funky, wet winters throughout the year. Rome ranks first in the list of most visited cities in Europe and has a special place in everyone’s bucket list. The most popular tourist icons of the city are Colosseum, Roman Forum, Trevi Fountain, Piazza Navona, St. Peter's Square, St. Peter's Basilica, Sistine Chapel, Piazza di Spagna, The Spanish Steps, Pantheon, Appian Way, National Roman Museum.

As indicated by the most recent WHO information distributed in 2017 Alzheimer’s/Dementia Deaths in Italy achieved 36,003 or 6.80% of aggregate passing. The age balanced Death Rate is 19.81 for every 100,000 of populace positions Italy ranks 74 on the planet. To address this issue, the global meeting is being organized in this venue, such that it would be appropriate to discuss.

Why to attend?

Who should attend?

Physicians

Geriatricians

Students

Clinical Neurologist

Speech Therapists

Research Faculty

Scientists and professors

Physical Therapists

Nurses

Health Organizations

Social Workers

Persons living with Dementia

Dementia Advocates

Neurologists

Health Care Analysts

Researchers in field of Neurology

Health care organizations

Geriatric Psychiatrists

All those providing care and treatment to patients with Dementia.

Around the world, around 44 million individuals are living with dementia, making the condition a worldwide crisis that must be addressed to. In Italy, more than 1.4 million individuals are living with dementia, the number of people living with dementia is projected to increase to 2.3 million in 2040 if prevalence proportions per age group are maintained, growing at 2.1% per year, compared with a decrease of 0.1% per year for the general population

The following graph shows the estimated number of people with dementia between 30 – 95* Age group affected with Dementia.

List of Universities carrying out research in Dementia across the globe:

Dalhousie University
University of Nottingham
Leiden University
Cardiff University
Temple University USA
University of Toronto
University Oklahoma
University Sheffield
University of Bristol
University California
Florida International University
University of Amsterdam
University of Edinburgh
Karolinska Institute
University of Milan
University of Gothenburg

List of Universities carrying out research in Dementia in Italy,

University of Milan
Vita-Salute San Raffaele University
Sapienza University of Rome
University of Bologna
University of Turin
University of Padua
University of Trieste
University of Trento
University of Pavia
Scuola Normale Superior di Pisa

Both the Government and the Charities help the universities and the Collaborative Research centres to carry out Dementia research in developing novel medicines for dementia.

Major Dementia and Alzheimer’s Societies and Associations across the Globe:

Alzheimer's Australia
Hilarescere Foundation in Italy
Alzheimer Society of Bangladesh
Alzheimer Support Group
Alzheimer's Association
Southern Clinical Neurological Society
American Academy of Neurology
ESNR European Society of Neuroradiology
European Neurological Societies
Alzheimer Austria
Foundation Alzheimer Aruba (FAA)
Alzheimer's disease Chinese
Spanish Society of Neurology
Alzheimer's Society
Major Neurological Associations in Italy
British brain tumor association
Alzheimer’s Europe
Medical Research Council (MRC)
The Dementia Discovery Fund
Alzheimer’s Society
UK Department of Health

The list of Governmental funding agents, Non-Governmental Organizations and Companies providing funds for Dementia Research in Europe includes the following,

Biogen
GSK
Johnson and Johnson
Lilly
Pfizer
Takeda

Drugs that are available in the market for the treatment of dementia includes Memantine, Donepezil, Rivastigmine, Galantamine. Among these drugs Donepezil is considered as the most effective one, since it has cured dementia in about 59,931 people. It is also reported that about 30,000 people are treated with Rivastigmine. The Memantine ranks third in treating about 14,640 patients, the Galantamine drug cures Dementia in about 10,000 patients.

The other drugs include:

Aricept™
Exelon™
Reminyl™
Ebixa®

Past Conference Report

Dementia Care 2018 Report:

Thanks to all our wonderful speakers, conference attendees and Sponsors, Dementia Care 2018 Conference was our best ever!

With a great support from our Collaborators and Organizing Committee, PULSUS Conferences successfully completed the “9th International Conference on Dementia and Dementia Care (Dementia Care 2018)” which was held at Renaissance London Heathrow Hotel, London, UK on 24-25, 2018.

We would like to thank our Organizing Committee Members and our Keynote Speakers comprising-

Simon Hooper, CEO, Remind Mecare, UK,
Markku Kurkinen, Professor Wayne State University School of Medicine USA,
Joe Sam Robinson, President Georgia Neurosurgical Institute Georgia, USA,
Solaphat Hemrungrojn, Chulalongkorn University, Thailand

for their support in making this event a great success.

We would also like to thank our Moderator-, Iemma Rocco Stefano, Manchester Metropolitan University, UK for being a great support for our event to be a grand success.

We would like to extend our thanks to our collaborators “

Remind Me Care,
Alive Inside foundation,
New York Academy of Sciences,
ISET”

for their constant support. It wouldn’t have been possible without the support of our Media Partners who helped us in promoting this event. We thank our Media partners for their support in helping us reach greater audience.

We also would like to thank all our Speakers, Poster Presenters and Delegates for taking out your time and sharing their research work with our peer network. We are very glad to have shared a great relationship with all these Attendees, associations and we hope to see even greater support in our upcoming events.

With a great response and feedback which we received at this event Pulsus Conferences is proud to announce our upcoming conferences in the Series of Healthcare Conferences-

Next in Series: 10thInternational Conference on Dementia and Dementia Care

July 24-25, 2019

Rome, Italy

To know more visit: https://dementia.cmesociety.com/2018/past-report